Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-30

Clinical Trial Update: Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating abatacept (Orencia) for primary biliary cirrhosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abatacept (abatacept)

Snippet

Sponsor: Christopher Bowlus, MD | Conditions: Primary Biliary Cirrhosis | Phase 4 | Status: COMPLETED | Results posted: 2020-03-30